Amyloid Inhibitors: Lysine-Derived Carbon Dots for Chiral Inhibition of Prion Peptide Fibril Assembly (Adv. Therap. 4/2018)

Advanced Therapeutics - United Kingdom
doi 10.1002/adtp.201870008
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Masthead (Adv. Therap. 4/2018)

Advanced Therapeutics
BiochemistryMedicineGeneticsPharmacologyPharmaceutical Science
2018English

Masthead (Adv. Therap. 8/2018)

Advanced Therapeutics
BiochemistryMedicineGeneticsPharmacologyPharmaceutical Science
2018English

Masthead (Adv. Therap. 7/2018)

Advanced Therapeutics
BiochemistryMedicineGeneticsPharmacologyPharmaceutical Science
2018English

Masthead (Adv. Therap. 3/2018)

Advanced Therapeutics
BiochemistryMedicineGeneticsPharmacologyPharmaceutical Science
2018English

Masthead (Adv. Therap. 4/2019)

Advanced Therapeutics
BiochemistryMedicineGeneticsPharmacologyPharmaceutical Science
2019English

Probing Peptide Domains Implicated in Amyloid Fibril Formation During Amelogenin Nanoribbon Assembly

Biophysical Journal
Biophysics
2018English

Inhibition of Alzheimer Β-Peptide Fibril Formation by Serum Amyloid P Component

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Human Anti-Prion Antibodies Block Prion Peptide Fibril Formation and Neurotoxicity

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

Kinetic Studies of Amyloid Β-Protein Fibril Assembly

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy